AI MARKET SCANNING

AbbVie Inc.

AVG HISTORICAL GAP -1.09%
MAX GAP RECORD -10.49%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $ABBV
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Oct 30, 2026 Earnings Release 2026-10-30 (BEFORE OPEN (08:00))
+0.00%
Jul 31, 2026 Earnings Release 2026-07-31 (BEFORE OPEN)
-1.89%
May 01, 2026 Earnings Release 2026-05-01 (AFTER CLOSE)
-0.68%
Feb 04, 2026 Earnings Release 2026-02-04 (BEFORE OPEN)
-7.04%
Oct 31, 2025 Earnings Release 2025-10-31 (BEFORE OPEN)
-2.28%
Jul 25, 2025 Earnings Release 2025-07-25 (BEFORE OPEN)
+0.04%
Apr 25, 2025 Earnings Release 2025-04-25 (BEFORE OPEN)
+3.74%
Jan 31, 2025 Earnings Release 2025-01-31 (BEFORE OPEN)
+6.63%

VOLATILITY & GAP BIAS

AVG GAP MOVE 3.2%
Bullish Gaps (5)
Bearish Gaps (6)
Neutral / Flat (4)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $ABBV

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗